Despite enormous progress in cancer therapy, many patients still relapse because their treatment addresses the symptoms of the disease rather than the cause, the so-called stem cells. New work has given a tantalizing clue to a solution. Scientists report that the cell-cycle kinase CDK6 is required for activation of the stem cells responsible for causing leukemia.